These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 29656364)
1. Characteristic appearances of fundus autofluorescence in treatment-naive and active polypoidal choroidal vasculopathy: a retrospective study of 170 patients. Zhao X; Xia S; Chen Y Graefes Arch Clin Exp Ophthalmol; 2018 Jun; 256(6):1101-1110. PubMed ID: 29656364 [TBL] [Abstract][Full Text] [Related]
2. A Comparison Study of Polypoidal Choroidal Vasculopathy Imaged with Indocyanine Green Angiography and Swept-Source Optical Coherence Tomography Angiography. Kim K; Yang J; Feuer W; Gregori G; Kim ES; Rosenfeld PJ; Yu SY Am J Ophthalmol; 2020 Sep; 217():240-251. PubMed ID: 32445699 [TBL] [Abstract][Full Text] [Related]
4. Evaluating Polypoidal Choroidal Vasculopathy With Optical Coherence Tomography Angiography. Wang M; Zhou Y; Gao SS; Liu W; Huang Y; Huang D; Jia Y Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT526-32. PubMed ID: 27472276 [TBL] [Abstract][Full Text] [Related]
5. Presenting characteristics and prevalence of polypoidal choroidal vasculopathy in Scandinavian patients with treatment-naïve exudative age-related macular degeneration. Lorentzen TD; Subhi Y; Sørensen TL Acta Ophthalmol; 2018 Aug; 96(5):475-480. PubMed ID: 29193780 [TBL] [Abstract][Full Text] [Related]
6. Characteristics of Polypoidal Choroidal Vasculopathy Evaluated by Optical Coherence Tomography Angiography. Tomiyasu T; Nozaki M; Yoshida M; Ogura Y Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT324-30. PubMed ID: 27409489 [TBL] [Abstract][Full Text] [Related]
7. OCT vs. Indocyanine Green Angiography Features of Polypoidal Choroidal Vasculopathy. Chaikitmongkol V; Upaphong P; Patikulsila D; Bressler NM Ophthalmol Retina; 2018 Feb; 2(2):170-172. PubMed ID: 31047347 [No Abstract] [Full Text] [Related]
8. Polypoidal Choroidal Vasculopathy with Feeder Vessels: Characteristics, Fellow Eye Findings, and Long-term Treatment Outcomes. Hwang HJ; Kim JH; Chang YS; Kim JW; Kim CG Korean J Ophthalmol; 2017 Jun; 31(3):230-239. PubMed ID: 28534339 [TBL] [Abstract][Full Text] [Related]
9. Changes in fundus autofluorescence in polypoidal choroidal vasculopathy during 3 years of follow-up. Suzuki M; Gomi F; Sawa M; Ueno C; Nishida K Graefes Arch Clin Exp Ophthalmol; 2013 Oct; 251(10):2331-7. PubMed ID: 23604513 [TBL] [Abstract][Full Text] [Related]
10. Characteristics of Fundus Autofluorescence in Active Polypoidal Choroidal Vasculopathy. Öztaş Z; Menteş J; Nalçacı S; Barış M Turk J Ophthalmol; 2016 Aug; 46(4):165-168. PubMed ID: 28058151 [TBL] [Abstract][Full Text] [Related]
11. Characteristics of Polypoidal Choroidal Vasculopathy Evaluated by Multispectral Imaging. Zhang J; Yan Y; Yu Z; Liu L Ophthalmic Surg Lasers Imaging Retina; 2018 Dec; 49(12):e249-e255. PubMed ID: 30566710 [TBL] [Abstract][Full Text] [Related]
12. Novel Findings of Polypoidal Choroidal Vasculopathy via Optical Coherence Tomography Angiography. Seong S; Choo HG; Kim YJ; Kim JY; Lee JH; Oh HS; You YS; Kim SH; Kwon OW Korean J Ophthalmol; 2019 Feb; 33(1):54-62. PubMed ID: 30746912 [TBL] [Abstract][Full Text] [Related]
13. CHARACTERIZATION AND DIFFERENTIATION OF POLYPOIDAL CHOROIDAL VASCULOPATHY USING SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY. Cheung CMG; Yanagi Y; Mohla A; Lee SY; Mathur R; Chan CM; Yeo I; Wong TY Retina; 2017 Aug; 37(8):1464-1474. PubMed ID: 27828911 [TBL] [Abstract][Full Text] [Related]
14. Early changes of vascular lesions and responses to combined photodynamic therapy in patients with polypoidal choroidal vasculopathy. Asano-Shimizu K; Asano S; Murata H; Azuma K; Nomura Y; Inoue T; Ogawa A; Asaoka R; Obata R Int Ophthalmol; 2020 Jun; 40(6):1335-1345. PubMed ID: 32026179 [TBL] [Abstract][Full Text] [Related]
15. DETAILED CHARACTERIZATION OF CHOROIDAL MORPHOLOGIC AND VASCULAR FEATURES IN AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY. Gupta P; Ting DSW; Thakku SG; Wong TY; Cheng CY; Wong E; Mathur R; Wong D; Yeo I; Gemmy Cheung CM Retina; 2017 Dec; 37(12):2269-2280. PubMed ID: 28145972 [TBL] [Abstract][Full Text] [Related]
16. Two-year results of a treat-and-extend regimen with aflibercept for polypoidal choroidal vasculopathy. Morimoto M; Matsumoto H; Mimura K; Akiyama H Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):1891-1897. PubMed ID: 28669041 [TBL] [Abstract][Full Text] [Related]
17. Choroidal Vascular Abnormalities by Ultra-widefield Indocyanine Green Angiography in Polypoidal Choroidal Vasculopathy. Jeong A; Lim J; Sagong M Invest Ophthalmol Vis Sci; 2021 Feb; 62(2):29. PubMed ID: 33605985 [TBL] [Abstract][Full Text] [Related]
18. Appearance of Polypoidal Lesions in Patients With Polypoidal Choroidal Vasculopathy Using Swept-Source Optical Coherence Tomographic Angiography. Bo Q; Yan Q; Shen M; Song M; Sun M; Yu Y; Rosenfeld PJ; Wang F; Sun X JAMA Ophthalmol; 2019 Jun; 137(6):642-650. PubMed ID: 30998817 [TBL] [Abstract][Full Text] [Related]